1.
Yu TC, Chou WC. Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma. J Med Cases. 2026;17(5):231-237. doi:10.14740/jmc5313